This Phase 2 clinical trial showed that the medications effectiveness increased with higher doses
Cant see the box
[24] Finally, a 2020 Cochrane systematic review found insufficient evidence to suggest that metformin monotherapy reduced all-cause mortality, serious adverse events, cardiovascular mortality, non-fatal myocardial infarction, non-fatal stroke, or end-stage renal disease when compared to DPP-4 inhibitors for the treatment of type 2 diabetes
Most studies follow people for just a few months , so we don't have solid long-term data yet
Following HGF-mediated dimerization and autophosphorylation of the c-Met receptor, signaling proteins are recruited to the carboxy-terminal docking site, either directly or indirectly through growth factor receptor-bound protein 2 (Grb2) and Grb2-associated binder-1 (Gab1)
Nhng ai lm vic v tip xc nhiu vi nh sng